Printed from Voxsanity (voxsanity.com.au) — NCT05769036 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.
Back to Cardiomyopathy
Cardiomyopathy Trial, Recruiting
NCT05769036
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are willing to follow the study rules and have agreed in writing to take part
- You are between 18 and 80 years old (male or female)
- You have been diagnosed with heart failure caused by blocked arteries or another heart muscle problem
- You have had heart failure symptoms for at least 3 months before joining the study
- Your heart failure symptoms affect your daily life at least to a moderate degree
- Your heart is in a normal rhythm, your heart pumps at 35% or less of its full capacity, and your heart's electrical signal takes a long time to travel through it in a specific pattern (confirm with trial site)
- Your heart is in a normal rhythm, your heart pumps at 35% or less of its full capacity, and your heart's electrical signal is slightly slower than normal in a specific pattern (confirm with trial site)
- Your heart is in a normal rhythm, your heart pumps at 35% or less of its full capacity, and your electrical signal is slow but in a different pattern (confirm with trial site)
- You have an irregular heart rhythm called atrial fibrillation that won't go away, your heart pumps at less than 40% capacity, your heart rate is too fast and difficult to control, and doctors are considering a procedure to manage it
- You have heart failure, your heart pumps at less than 40% capacity, and you need a device to help keep your heart beating at a steady rate due to a very slow heart rate
- You already have a pacemaker or a defibrillator device implanted, you have developed heart failure symptoms with your heart pumping at less than 40% capacity despite being on the best available medicines, and your device is pacing the lower right part of your heart a lot of the time
- You are already taking the best available medicines for your heart failure
Who may not be able to join:
- You have had heart bypass surgery, artery widening, or a stent placed in the last 3 months
- You have had a heart attack in the last 3 months
- You are currently experiencing an acute (sudden) heart attack or related emergency
- You are scheduled to have heart bypass surgery, artery widening, or a stent placed
- You are on a waiting list for a heart transplant
- You already have a mechanical heart pump device implanted
- You currently have sudden inflammation of the heart muscle
- You have a disease where abnormal substances build up in the heart muscle (confirm with trial site)
- You have a condition where the heart muscle is abnormally thick
- You have a serious problem with one or more of your heart valves
- You are currently pregnant, breastfeeding, or not using reliable contraception if you could become pregnant
- You have a mental or physical condition that would prevent you from taking part
- You are unwilling or unable to follow the study procedures
- You have heart disease caused by rheumatic fever
- You have a mechanical (artificial) tricuspid heart valve
- You have another serious health condition that could affect the study (confirm with trial site)
- You are currently taking part in another study testing a new drug or medical device
- You would not be available for follow-up visits after joining
- You have severe kidney disease where your kidneys are working at a very low level
- Your life expectancy is 12 months or less
- You are already taking part in another remote health monitoring programme
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.
Contact this trial
Principal Investigator: Tariel A Atabekov, Ph.D., Cardiology Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences
Phone: +79528002625
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Status
Recruiting
Phase
Not Applicable
Sponsor
Tomsk National Research Medical Center of the Russian Academy of Sciences
Registry
ClinicalTrials.gov
Start date
1 October 2023
Est. completion
1 June 2028
Where this trial is recruiting
🇷🇺 Russia
Primary endpoints
All-cause mortality or worsening of heart failure requiring unplanned hospitalization (%)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 29 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.
Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.